Benign prostatic hyperplasia Posts on Medivizor
Navigation Menu

Benign prostatic hyperplasia Posts on Medivizor

Evaluating the pulsed solid-state Thulium: YAG laser in men with benign prostatic hyperplasia in a real-world setting

Evaluating the pulsed solid-state Thulium: YAG laser in men with benign prostatic hyperplasia in a real-world setting

Posted by on Oct 13, 2024 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the real-world experiences of patients treated with endoscopic enucleation of the prostate (EEP) with the solid-state Thulium laser system (Thulio) for benign prostatic hyperplasia (BPH) treatment. The studies concluded that Thulium laser EEP was a safe and effective treatment option for these...

Read More

Evaluating the safety and effectiveness of transperineal laser ablation of the prostate for men with enlarged prostates

Evaluating the safety and effectiveness of transperineal laser ablation of the prostate for men with enlarged prostates

Posted by on Sep 8, 2024 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study aimed to evaluate the effectiveness and safety of transperineal laser ablation (TPLA) of the prostate for patients with lower urinary tract symptoms (LUTS) due to an enlarged prostate. The data showed that TPLA was effective and safe for these patients. Some background Lower urinary tract symptoms (LUTS) such as urination...

Read More

Evaluating a double dose of tamsulosin in the management of patients with BPH not responding to standard tamsulosin treatment

Evaluating a double dose of tamsulosin in the management of patients with BPH not responding to standard tamsulosin treatment

Posted by on Aug 20, 2024 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness and safety of giving a double dose of tamsulosin (Flomax; 0.8 mg per day) to patients with benign prostatic hyperplasia (BPH) who did not respond to the standard tamsulosin dose (0.4 mg per day) and who could not have prostate surgery. The data showed that a double dose of tamsulosin was an...

Read More

Evaluating the effectiveness of holmium laser enucleation of the median lobe of the prostate on preserving sexual and urinary function in patients with benign prostatic hyperplasia.

Evaluating the effectiveness of holmium laser enucleation of the median lobe of the prostate on preserving sexual and urinary function in patients with benign prostatic hyperplasia.

Posted by on Jul 7, 2024 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness of holmium laser enucleation of the median lobe of the prostate (HoLEP) on preserving sexual and urinary function in patients with benign prostatic hyperplasia (BPH). The data showed that HoLEP significantly improved urinary function with preservation of ejaculation (sexual function) in these...

Read More

Comparing the outcomes between holmium laser enucleation of the prostate, open prostate surgery and robotic prostate surgery for patients with large prostates.

Comparing the outcomes between holmium laser enucleation of the prostate, open prostate surgery and robotic prostate surgery for patients with large prostates.

Posted by on May 26, 2024 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study compared the outcomes between holmium laser enucleation of the prostate (HOLEP), open simple prostate surgery (OSP), and robotic simple prostate surgery (RSP) in patients with benign prostate hypertrophy (BPH) and large prostates. The data showed that HoLEP was associated with a significantly shorter operative time, length of...

Read More

Evaluating the effectiveness and safety of Quisqualis indica extract for the treatment of patients with lower urinary tract symptoms.

Evaluating the effectiveness and safety of Quisqualis indica extract for the treatment of patients with lower urinary tract symptoms.

Posted by on Aug 27, 2023 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness and safety of Quisqualis indica (Rangoon creeper or Chinese honeysuckle; a type of plant) extract for the treatment of patients with lower urinary tract symptoms (LUTS). The data showed that Quisqualis indica extract was safe and effective for the treatment of these patients. Some background Benign...

Read More

Evaluating the outcomes of GreenLight laser photoselective vaporization in patients with large prostates for the treatment of benign prostatic hyperplasia.

Evaluating the outcomes of GreenLight laser photoselective vaporization in patients with large prostates for the treatment of benign prostatic hyperplasia.

Posted by on Apr 30, 2023 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the outcomes of GreenLight laser photoselective vaporization (PVP) in patients with large prostates for the treatment of benign prostatic hyperplasia (BPH). The data showed that GreenLight PVP was safe and effective in these patients. Some background Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement...

Read More

Evaluating the outcomes of single-pass versus multiple-pass during aquablation in patients with urinary symptoms due to benign prostatic hyperplasia.

Evaluating the outcomes of single-pass versus multiple-pass during aquablation in patients with urinary symptoms due to benign prostatic hyperplasia.

Posted by on Nov 22, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the outcomes of single-pass versus multiple-pass during aquablation in patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). The data showed that treatment with multiple passes during aquablation improved the urinary outcomes compared to a single pass in these patients. Some...

Read More

Comparing salvage and primary holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia.

Comparing salvage and primary holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia.

Posted by on Nov 5, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study compared the safety and effectiveness of salvage (S) and primary (P) holmium laser enucleation of the prostate (HoLEP) in patients with benign prostatic hyperplasia (BPH). It also evaluated what were the procedures leading to S-HoLEP in these patients. The authors concluded that S-HoLEP was similar to...

Read More

Evaluating the effectiveness of tadalafil alone, silodosin alone, and the combination of both in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Evaluating the effectiveness of tadalafil alone, silodosin alone, and the combination of both in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Posted by on Oct 16, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness of tadalafil (Cialis) alone, silodosin (Rapaflo) alone, and the combination of both in the treatment of lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). The data showed that a combination of tadalafil plus silodosin is more effective than either drug alone in...

Read More

Evaluating the short-term functional outcomes and safety of holmium and thulium fiber laser enucleation of the prostate treatment for patients with benign prostatic hyperplasia.

Evaluating the short-term functional outcomes and safety of holmium and thulium fiber laser enucleation of the prostate treatment for patients with benign prostatic hyperplasia.

Posted by on Sep 18, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the short-term functional outcomes and safety of holmium (HoLEP) and thulium fiber laser enucleation of the prostate (ThuFLEP) treatment for patients with benign prostatic hyperplasia (BPH). The data showed that both HoLEP and ThuFLEP surgeries are similar in terms of functional outcomes and safety in these patients....

Read More

Evaluating the effectiveness of adding dutasteride to tadalafil for improving lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Evaluating the effectiveness of adding dutasteride to tadalafil for improving lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Posted by on Sep 11, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness of adding dutasteride (Avodart) to tadalafil (Cialis) for the treatment of lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). The data showed that adding dutasteride to tadalafil is a good treatment option for improving LUTS in these patients. Some background...

Read More